Fulzos 250mg Injection is a prescription medicine used for breast cancer in post-menopausal women. It works by blocking estrogen, slowing cancer cell growth, and helping improve treatment outcomes.

Fulzos 250mg Injection is an oncology medicine used in hormone‑dependent breast cancer. By blocking estrogen activity in cancer cells, Fulzos 250mg Injection helps slow or stop tumor proliferation, supports symptom relief (such as pain and fatigue), and improves treatment outcomes when used as directed by your oncologist.

How it works: This estrogen‑receptor blocker reduces the effect of estrogen on tumor cells, limiting their ability to grow and spread.

Administration: Fulzos 250mg Injection is given as an intramuscular injection by a trained clinician; do not self‑administer.

Common side effects: Injection‑site pain, headache, nausea, hot flashes, fatigue, joint or bone pain. Seek medical advice if severe reactions occur.

Safety: Not for pregnancy or breastfeeding. Use with caution in liver/kidney disease or bleeding disorders. Avoid alcohol unless your doctor says otherwise.

Fulzos 250mg Injection is prescribed only after menopause and should be taken strictly under medical supervision. Patients are often advised to undergo regular liver function and kidney function tests while on this medicine. It is important to follow your doctor’s dosage schedule and never stop the treatment suddenly. Storing Fulzos 250mg Injection at room temperature, away from direct sunlight and moisture, ensures its stability. As part of breast cancer management, this medicine may be used alongside surgery, radiation, or other hormonal therapies to improve long-term outcomes. Always discuss any unusual side effects with your oncologist promptly.